DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--Nov. 27, 2019-- IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced that the IMV’s executive management team will participate in two upcoming investor conferences in December:
Piper Jaffray 31st Annual Healthcare Conference
Date: Wednesday, December 4, 2019
Presentation Time: 8:50 a.m. Eastern Time
Location: New York, NY
LD Micro 12th Annual Main Event
Date: Wednesday, December 11, 2019
Presentation Time: 4:20 p.m. Eastern Time (1:20 p.m. Pacific Time)
Location: Los Angeles, CA
A live webcast of these presentations will be available under “Events, Webcasts and Presentations” in the investors section of IMV’s website and a replay will be available approximately one hour after the presentation. Afterwards, it will be available for approximately 30 days.